A critical evaluation of the therapeutic range of indinavir.
about
Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAARTPopulation pharmacokinetics of indinavir in patients infected with human immunodeficiency virus.Pharmacokinetics of indinavir and ritonavir administered at 667 and 100 milligrams, respectively, every 12 hours compared with indinavir administered at 800 milligrams every 8 hours in human immunodeficiency virus-infected patients.Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV-infected patients.
P2860
A critical evaluation of the therapeutic range of indinavir.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A critical evaluation of the therapeutic range of indinavir.
@ast
A critical evaluation of the therapeutic range of indinavir.
@en
A critical evaluation of the therapeutic range of indinavir.
@nl
type
label
A critical evaluation of the therapeutic range of indinavir.
@ast
A critical evaluation of the therapeutic range of indinavir.
@en
A critical evaluation of the therapeutic range of indinavir.
@nl
prefLabel
A critical evaluation of the therapeutic range of indinavir.
@ast
A critical evaluation of the therapeutic range of indinavir.
@en
A critical evaluation of the therapeutic range of indinavir.
@nl
P2860
P356
P1476
A critical evaluation of the therapeutic range of indinavir
@en
P2093
Craig R Rayner
Jennifer L Marriott
P2860
P304
P356
10.1345/APH.1A467
P407
P577
2002-07-01T00:00:00Z